Trial Profile
A prospective, randomized to control heart rate with oral ivabradine in computed tomography coronary angiography
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Dec 2015
Price :
$35
*
At a glance
- Drugs Ivabradine (Primary)
- Indications Coronary artery disease
- Focus Diagnostic use; Therapeutic Use
- 03 Dec 2015 New trial record